AGV Discovery;Institut National de la Santé et de la Recherche Médicale (INSERM);Centre National de la Recherche Scientifique (CNRS);Université de Montpellier
发明人:
申请号：
EP16801735.8
公开号：
EP3377491B1
申请日:
2016.11.17
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
The present invention concerns a compound of formula (I): or one of its pharmaceutically acceptable salts, especially for use as inhibitors of the kinase ERK activity in particular ERK2 activity.
